Delivery Order 75N92023D00016-75N92025F00001

Award Date 9/23/25
Potential Completion Date 9/22/26
Potential Value $3.7M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the National Heart, Lung, and Blood Institute (NHLBI) to the New York Genome Center, Inc. (NYGC), a nonprofit academic research institution. The contract, awarded under the NHLBI's Trans-Omics for Precision Medicine (TOPMed) program, is for NYGC to provide centralized omics data analysis and management services to support precision medicine research. The contract has a ceiling value of $742,360.00 and a performance period ending on September 27, 2026. The...
This is a $13,468,050.00 definitive, firm-fixed-price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to the New York Genome Center, Inc. (NYGC), a nonprofit academic research institution. The contract is for special studies and analysis services, with no set-aside designation. NYGC has a $500 million indefinite delivery, indefinite quantity (IDIQ) contract with NHLBI for the Trans-Omics for Precision Medicine (TOPMed) program to provide...
This is a delivery order award to the New York Genome Center, Inc. (doing business as Nygc), a nonprofit academic research institution, under the Centralized Omic REsource for TOPMed (CORE) Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the National Heart, Lung, and Blood Institute (NHLBI). The order, valued at $5,906,039.00, is for the fifth year of the Centralized Omics Resource (CORE) project, which provides centralized omics data analysis and management services to support...
This federal contract award is for the Trans-Omics for Precision Medicine (TOPMed) for the Centralized Omics Resource (CORE) - RNA-Seq project in 2024, issued by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency. The prime contractor is the New York Genome Center, Inc. (NYGC), a non-profit academic research institution. The contract has a ceiling value of $7,001,570.38 and is a firm fixed-price delivery order with a period of performance through September 2026. NYGC has...
This is a $24,910,368.70 firm fixed-price delivery order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to The Broad Institute, Inc., a non-profit research organization. The contract is for task areas 2, 3, and 4 of the NHLBI's Trans-Omics for Precision Medicine (TOPMed) Centralized Omics Resource (CORE) initiative, which supports large-scale genomics research. The contract has an ultimate completion date of...
This federal contract award of $89,299.99 to the New York Genome Center, Inc. (Nygc) was issued by the Veterans Integrated Service Network 2 (a component of the U.S. Department of Veterans Affairs) to provide genome sequencing services in support of research. The contract is a firm fixed-price purchase order, with an ultimate completion date of December 31, 2021. Nygc is a nonprofit academic research institution that specializes in advanced genomic sequencing, analysis, and computational...
This federal contract award is for Next Generation Sequencing services in support of an ongoing research study. The contract was awarded to the New York Genome Center, Inc. (Nygc), a non-profit academic research institution specializing in advanced genomic sequencing, analysis, and computational services for federal agencies. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $26,020 and a period of performance through November 30, 2025. The funding agency is the...
This is a $274,036 fixed-price task order awarded to the New York Genome Center, Inc. (Nygc) by the National Cancer Institute (NCI) under the NCI Genomic Characterization Centers master IDIQ contract. The purpose is to provide DNA methylation arrays to support new studies by the Cancer Genomics Program over a 3-year period of performance from September 2020 to September 2023. This task order is fully funded and non-severable. Nygc is a nonprofit academic research institution that provides...
This is a delivery order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health, to The Broad Institute, Inc. The contract is for the Centralized Omics Resource (CORE) program, which supports the Trans-Omics for Precision Medicine (TOPMed) initiative. The contract has a ceiling value of $36,386,600.12 and runs through September 27, 2026. The Broad Institute, a non-profit research organization affiliated with MIT and Harvard,...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $23,370,908.70 Firm Fixed Price Delivery Order contract to The Broad Institute, Inc. for the NHLBI Trans-Omics for Precision Medicine (TOPMed) Centralized Omics Resource (CORE) program. This contract, which runs through September 25, 2026, supports genomic data generation, analysis, and management services for the TOPMed initiative, a large-scale research effort exploring the role of genomics in human health and disease. The Broad...
  • 75N92023D00016
    Indefinite Delivery Contract
  • 75N92023D00016-75N92025F00001
    Delivery Order

This is a $3,695,082 delivery order contract awarded by the National Heart, Lung and Blood Institute (NHLBI) to the New York Genome Center, Inc. (NYGC) for the NHLBI Trans-Omics for Precision Medicine (TOPMed) Centralized Omics Resource (CORE) program. The contract has a completion date of September 22, 2026 and uses a firm fixed price pricing model. NYGC is a non-profit organization that specializes in advanced genomic sequencing, analysis, and computational services for federal agencies. This contract award is part of NYGC's larger portfolio of federal contract vehicles and grant awards related to genomic research, including a $500 million TOPMed IDIQ contract and other awards from agencies like the National Cancer Institute and National Institute on Drug Abuse. The contract does not have a set-aside designation, reflecting the specialized nature of NYGC's services.

Generated 9/18/25, 10:48 AM